BioLife Solutions Inc logo

BLFS - BioLife Solutions Inc Share Price

$34.03 -2.3  -6.2%

Last Trade - 3:56pm

Mid Cap
Market Cap £854.8m
Enterprise Value £787.2m
Revenue £30.0m
Position in Universe 2622nd / 6647
Unlock BLFS Revenue
Relative Strength (%)
1m -11.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -23.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
6.19 6.45 8.23 11.0 19.7 27.4 46.9 69.5 +34.6%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, BioLifeSolutions Inc revenues increased 75% to $33.4M. Net incometotaled $4.8M vs. loss of $4.6M. Revenues reflect Productrevenue increase of 69% to $32M, Rental revenue increasefrom $182K to $1.3M. Net Income reflects Change in fairvalue of warrant liabilit increase from $14.9M (expense) to$4.5M (income), Change in fair value of contingent consiincrease from $0K to $1.5M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BLFS Revenue Unlock BLFS Revenue

Net Income

BLFS Net Income Unlock BLFS Revenue

Normalised EPS

BLFS Normalised EPS Unlock BLFS Revenue

PE Ratio Range

BLFS PE Ratio Range Unlock BLFS Revenue

Dividend Yield Range

BLFS Dividend Yield Range Unlock BLFS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BLFS EPS Forecasts Unlock BLFS Revenue
Profile Summary

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated March 25, 1998
Public Since November 8, 2007
No. of Shareholders: 161
No. of Employees: 151
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 32,735,912
Free Float (0.0%)
Eligible for
BLFS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BLFS
Upcoming Events for BLFS
Frequently Asked Questions for BioLife Solutions Inc
What is the BioLife Solutions Inc share price?

As of 3:56pm, shares in BioLife Solutions Inc are trading at $34.03, giving the company a market capitalisation of £854.8m. This share price information is delayed by 15 minutes.

How has the BioLife Solutions Inc share price performed this year?

Shares in BioLife Solutions Inc are currently trading at $34.03 and the price has moved by 0.153k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioLife Solutions Inc price has moved by 0.100k% over the past year.

What are the analyst and broker recommendations for BioLife Solutions Inc?

Of the analysts with advisory recommendations for BioLife Solutions Inc, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for BioLife Solutions Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will BioLife Solutions Inc next release its financial results?

BioLife Solutions Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the BioLife Solutions Inc dividend yield?

BioLife Solutions Inc does not currently pay a dividend.

Does BioLife Solutions Inc pay a dividend?

BioLife Solutions Inc does not currently pay a dividend.

When does BioLife Solutions Inc next pay dividends?

BioLife Solutions Inc does not currently pay a dividend.

How do I buy BioLife Solutions Inc shares?

To buy shares in BioLife Solutions Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioLife Solutions Inc?

Shares in BioLife Solutions Inc are currently trading at $34.03, giving the company a market capitalisation of £854.8m.

Where are BioLife Solutions Inc shares listed? Where are BioLife Solutions Inc shares listed?

Here are the trading details for BioLife Solutions Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: BLFS
What kind of share is BioLife Solutions Inc?

Based on an overall assessment of its quality, value and momentum, BioLife Solutions Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioLife Solutions Inc share price forecast 2021?

Shares in BioLife Solutions Inc are currently priced at $34.03. At that level they are trading at 21.86% discount to the analyst consensus target price of 0.00.

Analysts covering BioLife Solutions Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.19 for the next financial year.

How can I tell whether the BioLife Solutions Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioLife Solutions Inc. Over the past six months, the relative strength of its shares against the market has been 43.07%. At the current price of $34.03, shares in BioLife Solutions Inc are trading at 26.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioLife Solutions Inc PE Ratio?

We were not able to find PE ratio data for BioLife Solutions Inc.

Who are the key directors of BioLife Solutions Inc?

BioLife Solutions Inc's management team is headed by:

Roderick de Greef - CFO
Raymond Cohen - CHM
Michael Rice - PRE
Andrew Hinson - IND
Aby Mathew - EVP
Joseph Schick - IND
Todd Berard - CMO
Karen Foster - OTH
Marcus Schulz - OTH
Sarah Aebersold - VPR
Who are the major shareholders of BioLife Solutions Inc?

Here are the top five shareholders of BioLife Solutions Inc based on the size of their shareholding:

Casdin Capital, LLC Hedge Fund
Percentage owned: 22.73% (7.44m shares)
WAVI Holding AG Corporation
Percentage owned: 12.05% (3.94m shares)
Taurus4757 GmbH Corporation
Percentage owned: 5.02% (1.64m shares)
Wasatch Global Investors Inc Investment Advisor/Hedge Fund
Percentage owned: 4.08% (1.34m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.91% (1.28m shares)
Similar to BLFS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.